Universitätsklinik Balgrist
Zurich, 8008, Switzerland
NCT Number: NCT03343132
Adaptive gait assessements will be evaluated as a potential new marker for tracking locomotor recovery throughout rehabilitation of spinal cord injury subjects. To this end, controls, subacute and chronic patients will be assessed at two timepoints with 3 month standard rehabilitation inbetween. The specific assessments will require the participant to acitvely modulate their gait pattern to fullfill specific task constraints. Their performance will be assessed via 3D kinematics, kinetics and EMG and these measures will be used to describe the adaptive capacity that the patient retains. Sensitivity and specificity of these markers will be determined. With more sensitive descriptors of gait function and quality, locomotor rehabilitation for SCI can be better designed and smaller effects can be accurately measured.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Zurich, 8008, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Typical clinical therapy.
Time frame: Baseline and through study completion, an average of 4 months
Recording of movement tasks
University of Zurich
Other
Gait Adaptability: Tracking Locomotor Recovery After Incomplete Spinal Cord Injury Via Sensitive Assessments in a Virtual Reality Treadmill Environment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03015714
Basal Ganglia Diseases, Brain Diseases
Gravedona Ed Uniti, Como, Italy
View Trial DetailsNCT04947865
Brain Diseases, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT05510739
Basal Ganglia Diseases, Behavior
Stockholm, Sweden
View Trial DetailsNCT06497309
Brain Diseases, Cardiovascular Diseases
Budapest, Pest County, Hungary
View Trial Details